-
Synthetic Biology, Genomics & Advanced Therapeutics2 months agoSTAT+: After a rough stretch, mRNA gets a boost — at least for now
With clinical success on a personalized mRNA vaccine for melanoma, experts are hoping for a more stable future for the technology in other areas.
-
Synthetic Biology, Genomics & Advanced Therapeutics7 months ago
eXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback from Cayman Chemical
eXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback from Cayman Chemical
-
Synthetic Biology, Genomics & Advanced Therapeutics7 months ago
Electrorheoimaging Helps Manage Droplet Viscosity in Real-Time
Electrorheoimaging Helps Manage Droplet Viscosity in Real-Time
-
Synthetic Biology, Genomics & Advanced Therapeutics7 months ago
HDX-MS Plus Computational Methods Provide Novel Approach to Study of Protein-Protein Interactions
HDX-MS Plus Computational Methods Provide Novel Approach to Study of Protein-Protein Interactions
-
Synthetic Biology, Genomics & Advanced Therapeutics7 months ago
Benchtop Bioreactor Simplifies Macrophage Manufacturing
Benchtop Bioreactor Simplifies Macrophage Manufacturing
-
Synthetic Biology, Genomics & Advanced Therapeutics7 months ago
CAR T Production Bottlenecks Best Tackled with AI, Automation, and Skilled Staff
CAR T Production Bottlenecks Best Tackled with AI, Automation, and Skilled Staff
Clinical Trials & Development13 hours ago
Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout
Clinical Trials & Development13 hours ago
Genmab’s cancer bispecific delivers early OS win in ‘exceedingly positive’ Phase 3 readout
Helixgate Featured14 hours ago
STAT+: HHS moves to allow compounding of some unapproved peptides
Uncategorized7 months ago
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Endpoints News7 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Uncategorized6 months ago
